Analysis Article • 11h

The Clinical Research and Equipment is pretty flat in the last 7 days, but MedCap has stood out, gaining 8.3%. As for the longer term, the industry has declined 18% in the last year. Earnings are forecast to grow by 17% annually.
Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 27 Jul 2026 | SEK 30.2b | SEK 14.7b | -SEK 829,177,579.00 | 34.6x | -36.4x | 2.1x |
| Wed, 24 Jun 2026 | SEK 29.4b | SEK 14.6b | -SEK 871,304,353.00 | 34.2x | -33.7x | 2x |
| Fri, 22 May 2026 | SEK 29.7b | SEK 14.6b | -SEK 850,163,077.00 | 37.1x | -35x | 2x |
| Sun, 19 Apr 2026 | SEK 31.3b | SEK 14.6b | -SEK 971,664,077.00 | 36.3x | -32.2x | 2.1x |
| Tue, 17 Mar 2026 | SEK 26.9b | SEK 14.6b | -SEK 838,374,077.00 | 32.4x | -32.1x | 1.8x |
| Thu, 12 Feb 2026 | SEK 27.1b | SEK 14.9b | -SEK 555,615,427.00 | 32.9x | -48.8x | 1.8x |
| Sat, 10 Jan 2026 | SEK 30.7b | SEK 14.9b | -SEK 744,515,427.00 | 48x | -41.3x | 2.1x |
| Mon, 08 Dec 2025 | SEK 33.4b | SEK 14.9b | -SEK 744,515,427.00 | 55.6x | -44.9x | 2.3x |
| Wed, 05 Nov 2025 | SEK 36.9b | SEK 14.8b | SEK 117.3m | 55.3x | 314.8x | 2.5x |
| Fri, 03 Oct 2025 | SEK 34.0b | SEK 14.7b | SEK 61.3m | 58.7x | 555x | 2.3x |
| Sun, 31 Aug 2025 | SEK 34.9b | SEK 14.7b | SEK 59.9m | 58.4x | 583.6x | 2.4x |
| Tue, 29 Jul 2025 | SEK 36.6b | SEK 14.8b | SEK 186.0m | 66x | 196.9x | 2.5x |
| Thu, 26 Jun 2025 | SEK 45.3b | SEK 16.6b | SEK 405.8m | 71.1x | 111.7x | 2.7x |
| Sat, 24 May 2025 | SEK 45.0b | SEK 16.6b | SEK 401.6m | 68.5x | 112.1x | 2.7x |
| Mon, 21 Apr 2025 | SEK 36.9b | SEK 16.6b | SEK 609.4m | 39.6x | 60.5x | 2.2x |
| Wed, 19 Mar 2025 | SEK 37.8b | SEK 16.6b | SEK 614.9m | 38x | 61.5x | 2.3x |
| Fri, 14 Feb 2025 | SEK 44.0b | SEK 17.0b | -SEK 1,038,511,426.00 | 43.2x | -42.4x | 2.6x |
| Sun, 12 Jan 2025 | SEK 43.7b | SEK 16.7b | -SEK 1,152,911,426.00 | 49.5x | -37.9x | 2.6x |
| Tue, 10 Dec 2024 | SEK 43.8b | SEK 16.7b | -SEK 1,152,911,426.00 | 51x | -38x | 2.6x |
| Thu, 07 Nov 2024 | SEK 42.5b | SEK 16.8b | -SEK 958,019,827.00 | 48.9x | -44.3x | 2.5x |
| Sat, 05 Oct 2024 | SEK 47.2b | SEK 16.7b | -SEK 988,175,491.00 | 58.9x | -47.7x | 2.8x |
| Mon, 02 Sep 2024 | SEK 49.5b | SEK 16.7b | -SEK 987,374,492.00 | 62.9x | -50.1x | 3x |
| Wed, 31 Jul 2024 | SEK 49.5b | SEK 16.7b | -SEK 1,128,120,510.00 | 62.2x | -43.9x | 3x |
| Fri, 28 Jun 2024 | SEK 41.6b | SEK 16.3b | -SEK 1,188,686,510.00 | 54.3x | -35x | 2.5x |
| Sun, 26 May 2024 | SEK 42.2b | SEK 16.3b | -SEK 1,188,686,510.00 | 60.1x | -35.5x | 2.6x |
| Tue, 23 Apr 2024 | SEK 36.6b | SEK 16.0b | -SEK 1,122,732,213.00 | 34.3x | -32.6x | 2.3x |
| Thu, 21 Mar 2024 | SEK 38.4b | SEK 16.0b | -SEK 1,123,039,210.00 | 34.1x | -34.2x | 2.4x |
| Sat, 17 Feb 2024 | SEK 41.0b | SEK 15.8b | -SEK 1,466,735,350.00 | 50.7x | -28x | 2.6x |
| Mon, 15 Jan 2024 | SEK 38.3b | SEK 15.5b | -SEK 1,393,723,683.00 | 47x | -27.5x | 2.5x |
| Wed, 13 Dec 2023 | SEK 35.2b | SEK 15.5b | -SEK 1,393,723,683.00 | 42.6x | -25.2x | 2.3x |
| Fri, 10 Nov 2023 | SEK 31.7b | SEK 15.4b | -SEK 1,256,647,710.00 | 35.2x | -25.3x | 2.1x |
| Sun, 08 Oct 2023 | SEK 26.1b | SEK 15.1b | -SEK 1,134,516,711.00 | 36.2x | -23x | 1.7x |
| Tue, 05 Sep 2023 | SEK 30.5b | SEK 15.1b | -SEK 1,134,263,831.00 | 42.1x | -26.9x | 2x |
| Thu, 03 Aug 2023 | SEK 31.7b | SEK 15.1b | -SEK 213,871,038.00 | 45.3x | -148.4x | 2.1x |
-148.4x
How does Swedish Clinical Research and Equipment compare with similar industries?
| SE Market | 0.87% | |
| Healthcare | -2.08% | |
| Life Sciences | 0.40% | |
| Clinical Research and Equipment | 0.40% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MCAP MedCap | SEK 556.50 | 11.6% +SEK 845.4m | -14.5% | PE34.6x | |
| GENO Genovis AB (publ.) | SEK 20.05 | 4.2% +SEK 81.5m | -28.1% | PE66x | |
| ALIF B AddLife | SEK 157.50 | 0.3% +SEK 60.9m | -8.9% | PE32.1x |